Intero Biosystems
- Headquarters
- Sugar Land, Texas
- Business Model
- B2B
- Website
- interobiosystems.com
- Last Round
- Pre-SeedJun 2025
About
Intero Biosystems develops gut organoid technology — miniaturized, lab-grown intestinal tissue models — for use in personalized medicine and pharmaceutical drug testing. The company's platform enables more accurate preclinical testing by using patient-derived tissue to predict individual drug responses, reducing reliance on animal models and improving drug development success rates.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free AccountInvestors
Sign up to view investors
Create a free account to see which investors have funded this company.
Create Free Account